World Health Organization unanimously approves plan to improve epilepsy care, reduce stigma

On 27 May 2022, World Health Organization Member States unanimously approved the Intersectoral Global Action Plan on Epilepsy and other Neurological Disorders (IGAP) at the 75th World Health Assembly in Geneva, Switzerland.

University of Kentucky Human Development Institute Resources for Families of Infants With Down Syndrome Formally Recommended by American Academy of Pediatrics

In a clinical report released on April 18, the American Academy of Pediatrics recommended resources administered by the University of Kentucky Human Development Institute (HDI) to pediatricians across the nation. These resources are recommended to be distributed by pediatricians to families learning about a prenatal diagnosis of Down syndrome.

Lack of affordable childcare is still a burden for plastic surgery residents – Especially women

Plastic surgery residents face persistent barriers accessing affordable childcare, with high costs and a major impact on surgical training – with most of the burden falling on women residents, reports a paper in the June issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons (ASPS). Plastic and Reconstructive Surgery® is published in the Lippincott portfolio by Wolters Kluwer.

Firearms Are Leading Cause of Death Among U.S. Youth

Firearms are now the leading cause of death for children and adolescents 0-19 years of age, with a staggering 83 percent increase in youth firearm fatalities over the past decade, according to a commentary published in Lancet Child and Adolescent Health. Nearly two-thirds of youth firearm deaths were from homicides. Strikingly, Black youth had an unprecedented 40 percent increase in firearm fatalities between 2019 to 2020.

Cedars-Sinai Cancer Experts Present Breakthroughs at 2022 ASCO Annual Meeting

Experts from Cedars-Sinai Cancer, ranked among the top 10 in the nation for cancer care, will present novel research and clinical advances throughout the 2022 annual meeting of the American Society of Clinical Oncology (ASCO), taking place in person and virtually June 3-7 in Chicago.

Researchers aim X-rays at century-old plant secretions for insight into Aboriginal Australian cultural heritage

For tens of thousands of years, Aboriginal Australians have created some of the world’s most striking artworks. Today their work continues long lines of ancestral traditions, stories of the past and connections to current cultural landscapes, which is why researchers are keen on better understanding and preserving the cultural heritage within.

Race, ethnicity, and poverty linked to worse outcomes in children treated for high-risk neuroblastoma

Children with high-risk neuroblastoma had worse outcomes if they were from certain racial/ethnic groups or were on public rather than private insurance, despite being treated in clinical trials with standardized protocols, according to a study led by investigators from Dana-Farber/Boston Children’s Cancer and Blood Disorders Center.

MD Anderson Research Highlights: ASCO 2022 Special Edition

This special edition features upcoming oral presentations by MD Anderson researchers at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting focused on quality improvement, health services research, new treatments for skin cancers, and symptoms and survivorship advances. More information on ASCO content from MD Anderson can be found at MDAnderson.org/ASCO.

Targeted agents, combination therapies, and clinical trial equity headline Dana-Farber research at ASCO Annual Meeting

Several phase 3 studies conducted by researchers from Dana-Farber Cancer Institute show promising results for patients with multiple myeloma and breast cancer. The results of these studies, along with dozens of others led by Dana-Farber researchers, will be presented at the 2022 Annual Meeting of the American Society of Clinical Oncology (ASCO).

Next-Generation Immunotherapy Drug Shows Continued Promise in Several Advanced-Stage Cancers

Initial study results show that an experimental drug, called nemvaleukin alfa, when used alone or in combination with another anticancer drug (pembrolizumab) may be effective in treating several types of late-stage cancers in some patients.

New research questions previous link between diabetes drugs and bone fractures

• Although clinical trials have linked diabetes medications called sodium glucose transport-2 inhibitors to higher bone fracture risks, a large study found no additional risks when the medications were compared with diabetes drugs not associated with fractures.
• The findings applied to older adults with normal kidney function as well as to those with mild or moderate kidney disease.

Mystery mechanism in small peptide shows big promise for fighting antibiotic-resistant bacteria

Using neutrons, researchers at Oak Ridge National Laboratory pieced together the molecular mechanics behind a peptide’s ability to deal significant damage to bacterial cells. Their findings could inform new therapeutic strategies for treating bacterial infections where antibiotics have fallen short.

May Research Highlights

A Roundup of the Latest Medical Discoveries and Faculty News at Cedars-Sinai

MONKEYPOX MEDIA ADVISORY: Infectious Disease Specialists From Regional Special Pathogen Treatment Center Available to Discuss Monkeypox Causes and Treatments

Multiple cases of monkeypox have surfaced in Europe and the U.S. that do not appear to be linked to travel, causing concern among the medical community that this infectious disease is spreading through sexual contact or other close interactions.